PADT Invests in Kinetic Muscles

Last month, PADT invested in an exciting emerging company called Kinetic Muscles Inc. (KMI).  KMI is a Tempe based medical device company that has been working to develop a more effective treatment for stroke survivors.  Founded in 2001 by Jim and Ed Koeneman, KMI has been working steadily to develop and prove its technology and has received several prestigious awards - including Medical Device Company of the year from the Arizona Bioindustry Association.  
 
In 2007, KMI conducted a nationwide launch of their the "Hand Mentor Pro™".  The Hand Mentor™ helps stroke survivors regain use of their hand and wrist by engaging them in a series of game-like repetitive exercises that increasingly challenges the patient to move their hand on their own.  The product is based on the principal of neuroplasticity - which simply implies that a stroke impaired brain can relearn how to control the muscles with proper stimulation, effort, and time. 
 
KMI is now developing a number of additional rehabilitation products all targeting the $65 Billion dollar stroke market and based on the same technology resident in the Hand Mentor.  Simultaneously, KMI is expanding its marketing effort in the US and overseas to generate rapid growth.  To support this expansion, KMI is now accepting Angel and Venture Capital funding.  For more information, please contact KMI's CEO, Grant Farrell, gfarrell@kineticmuscles.com.

It’s Show Time

PADT Medical will be exhibiting in two medical device conferences this fall and we encourage you to come and visit us. On September 10^th and 11^th we will be exhibiting at the BIOMEDDevices conference in San Jose, CA. This conference is a comprehensive resource for medical device and biopharmaceutical development and manufacturing.

On October 29^th and 30^th, we will be exhibiting at the Third Annual Annual California Medical Device Forum in Orange County, CA. This conference is expected to draw over 500 participants from across the U.S. The past two years have been an exciting mix of entrepreneurs, start-ups, large companies, venture capitalists, the university sector and strategic advisors. The conference is organized by OCTANe, an organization is fueling "innovation development" in Orange County and Southern California. By connecting people, capital and technology, OCTANe accelerates entrepreneurs and company development for Orange County's biomedical and information technology community.

We hope to see you there.

PADT Medical Sponsors AZBio Peer-2-Peer Luncheon Series

PADT Medical is sponsoring a Peer-2-Peer Luncheon series focused on issues faced by Bioscience companies based in Arizona. Every first Thursday of the month, senior representatives of bioscience companies are invited to participate in round-table discussions. The topic for September 11th centers on "Developing your Target Product Profile". The luncheon will be hosted at Dave & Buster's in Tempe. We encourage you and your colleagues to participate in the series. To learn more about the luncheon series and to reserve your seat click here.

PADT Medical is an active member of the Arizona BioIndustry Association (AZBio). AZBio seeks to unify, empower and advance its member organizations, who collectively form Arizona's bioscience community. As the unified voice of the bioscience industry in Arizona, AZBio strives to make Arizona a place where bioscience companies can grow and succeed. Click here for more information about AZBio.

Phase 1: Planning – Plans You Can Plan On

When it comes to developing medical devices there are several plans that you can plan on. The second phase of our Product Development Process (See previous blog, Link) is the Planning Phase. We use this stage of the PDP to help our customers establish that all important "Guidance Documents". We rely on a trio of planning document to establish the roadmap to market. These documents are the Quality Plan, Design Plan, and the Risk Management Plan.

It is tempting to think that establishing these documents only delays the development process. We have found that, if done right, these documents can ultimately lead to a shorter time to market by defining clear roles and responsibilities, design strategy and priorities, and ground rules for risk mitigation activities. These documents also outline how the FDA Design Control regulations will be satisfied.

At PADT Medical, we help our customers establish these documents in accordance with your business and product development objectives. We have existing protocols and templates that we can draw from to streamline the planning process and help you take your product to market in a controlled and well-planned process.